Overview Dividends

(BLMN) Bloomin Brands - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0942351083

Casual, Polished Casual, Fine Dining, Steakhouse, Italian

BLMN EPS (Earnings per Share)

EPS Growth (3Y CAGR): -61.16%
EPS Trend (3Y Correlation): -77.8%

BLMN Revenue

Revenue Growth (3Y CAGR): -1.87%
Revenue Trend (3Y Correlation): -51.7%

Risk via 10d forecast
Volatility	63.6%
Value at Risk 5%th	95.2%
Relative Tail Risk	-8.91%

Reward TTM
Sharpe Ratio	-0.49
Alpha	-63.38

Character TTM
Hurst Exponent	0.495
Beta	1.414
Beta Downside	1.349

Drawdowns 3y
Max DD	77.68%
Mean DD	33.25%
Median DD	22.54%

Description: BLMN Bloomin Brands October 22, 2025

Bloomin’ Brands, Inc. (NASDAQ:BLMN) operates a portfolio of four restaurant concepts-Outback Steakhouse, Carrabba’s Italian Grill, Bonefish Grill, and Fleming’s Prime Steakhouse & Wine Bar-through both U.S. and International Franchise segments. Founded in 1988 and headquartered in Tampa, Florida, the company runs casual to fine-dining venues across the United States and select overseas markets.

Recent performance highlights include FY 2023 comparable-store sales declining roughly 2% year-over-year, while franchise revenue now represents about 45% of total revenue, reflecting a strategic shift toward higher-margin franchising. The sector remains sensitive to consumer discretionary spending and input-cost inflation, with labor and food cost pressures compressing operating margins across the casual dining industry.

For a deeper, data-driven view of Bloomin’ Brands’ valuation dynamics, you might find the analytical tools on ValueRay useful for extending this initial assessment.

BLMN Stock Overview

Market Cap in USD	615m
Sub-Industry	Restaurants
IPO / Inception	2012-08-08
Return 12m vs S&P 500	-52.7%
Analyst Rating	3.0 of 5

BLMN Dividends

Dividend Yield	10.19%
Yield on Cost 5y	4.89%
Yield CAGR 5y	48.02%
Payout Consistency	77.3%
Payout Ratio	61.6%

BLMN Growth Ratios

CAGR 3y	-30.81%
CAGR/Max DD Calmar Ratio	-0.40
CAGR/Mean DD Pain Ratio	-0.93
Current Volume	1974.3k
Average Volume	2255.8k

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (-4.98m TTM) > 0 and > 6% of Revenue (6% = 243.8m TTM)

FCFTA 0.02 (>2.0%) and ΔFCFTA 0.45pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -10.96% (prev -12.63%; Δ 1.68pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.07 (>3.0%) and CFO 235.1m > Net Income -4.98m (YES >=105%, WARN >=100%)

Net Debt (2.11b) to EBITDA (268.6m) ratio: 7.85 <= 3.0 (WARN <= 3.5)

Current Ratio 0.43 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (85.1m) change vs 12m ago -3.94% (target <= -2.0% for YES)

Gross Margin 92.69% (prev 14.18%; Δ 78.52pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 121.2% (prev 135.2%; Δ -13.93pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.84 (EBITDA TTM 268.6m / Interest Expense TTM 56.1m) >= 6 (WARN >= 3)

Altman Z'' -1.83

(A) -0.13 = (Total Current Assets 332.0m - Total Current Liabilities 777.2m) / Total Assets 3.31b

(B) -0.26 = Retained Earnings (Balance) -858.3m / Total Assets 3.31b

(D) -0.29 = Book Value of Equity -853.2m / Total Liabilities 2.91b

Total Rating: -1.83 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 47.41

1. Piotroski 3.0pt = -2.0

2. FCF Yield 2.26% = 1.13

3. FCF Margin 1.51% = 0.38

4. Debt/Equity 5.43 = -2.50

5. Debt/Ebitda 7.85 = -2.50

6. ROIC - WACC (= 8.76)% = 10.95

7. RoE -1.72% = -0.29

8. Rev. Trend -51.66% = -3.87

9. EPS Trend -77.81% = -3.89

What is the price of BLMN shares?

As of November 16, 2025, the stock is trading at USD 6.77 with a total of 1,974,311 shares traded.
Over the past week, the price has changed by +1.42%, over one month by -11.96%, over three months by -4.77% and over the past year by -45.74%.

Is Bloomin Brands a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Bloomin Brands (NASDAQ:BLMN) is currently (November 2025) a stock to sell. It has a ValueRay Fundamental Rating of 47.41 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BLMN is around 6.19 USD . This means that BLMN is currently overvalued and has a potential downside of -8.57%.

Is BLMN a buy, sell or hold?

Bloomin Brands has received a consensus analysts rating of 3.00. Therefor, it is recommend to hold BLMN.

Strong Buy: 1
Buy: 0
Hold: 10
Sell: 2
Strong Sell: 0

What are the forecasts/targets for the BLMN price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	7.8	14.8%
Analysts Target Price	7.8	14.8%
ValueRay Target Price	6.6	-3.1%

BLMN Fundamental Data Overview November 07, 2025

Market Cap USD = 615.0m (615.0m USD * 1.0 USD.USD)
P/E Trailing = 8.1236
P/E Forward = 6.1996
P/S = 0.1563
P/B = 1.5504
P/EG = 1.07
Beta = 1.136
Revenue TTM = 4.06b USD
EBIT TTM = 103.2m USD
EBITDA TTM = 268.6m USD
Long Term Debt = 917.1m USD (from longTermDebt, last quarter)
Short Term Debt = 162.5m USD (from shortTermDebt, last quarter)
Debt = 2.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.11b USD (from netDebt column, last quarter)
Enterprise Value = 2.72b USD (615.0m + Debt 2.16b - CCE 50.3m)
Interest Coverage Ratio = 1.84 (Ebit TTM 103.2m / Interest Expense TTM 56.1m)
FCF Yield = 2.26% (FCF TTM 61.5m / Enterprise Value 2.72b)
FCF Margin = 1.51% (FCF TTM 61.5m / Revenue TTM 4.06b)
Net Margin = -0.12% (Net Income TTM -4.98m / Revenue TTM 4.06b)
Gross Margin = 92.69% ((Revenue TTM 4.06b - Cost of Revenue TTM 297.0m) / Revenue TTM)
Gross Margin QoQ = 70.24% (prev 15.52%)
Tobins Q-Ratio = 0.82 (Enterprise Value 2.72b / Total Assets 3.31b)
Interest Expense / Debt = 0.50% (Interest Expense 10.7m / Debt 2.16b)
Taxrate = -46.16% (negative due to tax credits) (-8.75m / 19.0m)
NOPAT = 150.9m (EBIT 103.2m * (1 - -46.16%)) [negative tax rate / tax credits]
Current Ratio = 0.43 (Total Current Assets 332.0m / Total Current Liabilities 777.2m)
Debt / Equity = 5.43 (Debt 2.16b / totalStockholderEquity, last quarter 397.2m)
Debt / EBITDA = 7.85 (Net Debt 2.11b / EBITDA 268.6m)
Debt / FCF = 34.24 (Net Debt 2.11b / FCF TTM 61.5m)
Total Stockholder Equity = 288.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.15% (Net Income -4.98m / Total Assets 3.31b)
RoE = -1.72% (Net Income TTM -4.98m / Total Stockholder Equity 288.9m)
RoCE = 8.56% (EBIT 103.2m / Capital Employed (Equity 288.9m + L.T.Debt 917.1m))
RoIC = 11.81% (NOPAT 150.9m / Invested Capital 1.28b)
WACC = 3.05% (E(615.0m)/V(2.77b) * Re(11.22%) + D(2.16b)/V(2.77b) * Rd(0.50%) * (1-Tc(-0.46)))
Discount Rate = 11.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -5.94%
[DCF Debug] Terminal Value 59.97% ; FCFE base≈56.0m ; Y1≈40.1m ; Y5≈21.9m
Fair Price DCF = 3.16 (DCF Value 268.6m / Shares Outstanding 85.1m; 5y FCF grow -33.35% → 3.0% )
EPS Correlation: -77.81 | EPS CAGR: -61.16% | SUE: 1.76 | # QB: 1
Revenue Correlation: -51.66 | Revenue CAGR: -1.87% | SUE: 0.10 | # QB: 0

Additional Sources for BLMN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle